CSL Limited
CSL
Kedudukan dalam Saham
#362
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Harga Saham
$138.58
Modal Pasaran
$66.50B
Perubahan (1 hari)
0.72%
Perubahan (1 tahun)
-2.29%
Negara
AU
Perdagangan CSL Limited (CSL)
Kategori
Healthcare
Sejarah pecahan saham untuk CSL Limited (CSL)
Saham CSL Limited (simbol: CSL) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Oct 18, 2007.
Satu saham CSL yang dibeli sebelum Oct 18, 2007 kini bersamaan dengan 3 saham CSL.
Pecahan saham terkini berlaku pada Oct 18, 2007.
Satu saham CSL yang dibeli sebelum Oct 18, 2007 kini bersamaan dengan 3 saham CSL.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
